Education
About Us
Working with TipRanks
Follow Us
Medifast Inc (MED)
NYSE:MED
Total Valuation
Medifast has a market cap or net worth of $144.97M. The enterprise value is $5.79M.
Market Cap$144.97M
Enterprise Value$5.79M
Share Statistics
Medifast has 10,991,064 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,991,064
Owned by Insiders4.71%
Owned by Institutions0.14%
Financial Efficiency
Medifast’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.70%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.70%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee1.20M
Profits Per Employee4.15K
Employee Count504
Asset Turnover2.12
Inventory Turnover3.72
Valuation Ratios
The current PE Ratio of Medifast is 41.6. Medifast’s PEG ratio is ―.
PE Ratio41.6
PS Ratio―
PB Ratio―
Price to Fair Value0.92
Price to FCF―
Price to Operating Cash Flow36.26
PEG Ratio―
Income Statement
In the last 12 months, Medifast had revenue of 602.46M and earned 2.09M in profits. Earnings per share was 0.19.
Revenue602.46M
Gross Profit444.62M
Operating Income2.88M
Pretax Income3.79M
Net Income2.09M
EBITDA15.59M
Earnings Per Share (EPS)0.19
Cash Flow
In the last 12 months, operating cash flow was 4.15M and capital expenditures -6.58M, giving a free cash flow of -2.42M billion.
Operating Cash Flow4.15M
Free Cash Flow-2.42M
Free Cash Flow per Share-0.22
Dividends & Yields
Medifast pays an annual dividend of $1.65, resulting in a dividend yield of ―
Dividend Per Share$1.65
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change-28.91%
50-Day Moving Average13.79
200-Day Moving Average15.14
Relative Strength Index (RSI)42.54
Average Volume (3m)201.40K
Important Dates
Medifast upcoming earnings date is Feb 24, 2026, After Close (Confirmed).
Last Earnings DateAug 4, 2025
Next Earnings DateFeb 24, 2026
Ex-Dividend DateSep 18, 2023
Financial Position
Medifast as a current ratio of 3.34, with Debt / Equity ratio of 6.05%
Current Ratio3.34
Quick Ratio2.68
Debt to Market Cap0.00
Net Debt to EBITDA-4.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medifast has paid 1.70M in taxes.
Income Tax1.70M
Effective Tax Rate0.45
Enterprise Valuation
Medifast EV to EBITDA ratio is 7.56, with an EV/FCF ratio of 6.92.
EV to Sales0.20
EV to EBITDA7.56
EV to Free Cash Flow6.92
EV to Operating Cash Flow4.81
Balance Sheet
Medifast has $162.67M in cash and marketable securities with $13.07M in debt, giving a net cash position of -$149.60M billion.
Cash & Marketable Securities$162.67M
Total Debt$13.07M
Net Cash-$149.60M
Net Cash Per Share-$13.61
Tangible Book Value Per Share$19.22
Margins
Gross margin is 73.84%, with operating margin of 0.48%, and net profit margin of 0.35%.
Gross Margin73.84%
Operating Margin0.48%
Pretax Margin0.63%
Net Profit Margin0.35%
EBITDA Margin2.59%
EBIT Margin0.48%
Analyst Forecast
The average price target for Medifast is $13.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$13.00
Price Target Upside-0.23% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-37.62%
EPS Growth Forecast-87.69%